PEDIATRICS Vol. 124 No. 1 July 2009, pp. e155-e162 (doi:10.1542/peds.2008-3726)
SPECIAL ARTICLE |
Pathways to Approval of Pediatric Cardiac Devices in the United States: Challenges and Solutions
a Division of Cardiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
b Division of Cardiac Surgery, Cleveland Clinic Foundation, Cleveland, Ohio
c Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota
d Division of Pediatric Cardiology, Seattle Children's Hospital, Seattle, Washington
e Division of Pediatric Cardiology, Children's Hospital of Omaha, Omaha, Nebraska
f Division of Pediatric Cardiology, San Diego Children's Hospital, San Diego, California
g Department of Cardiology, Children's Hospital Boston, Boston, Massachusetts
Patients treated by pediatric interventional cardiologists and cardiac surgeons often have unmet medical device needs that pose a challenge to the current regulatory evaluation and approval process in the United States. In this report we review current US Food and Drug Administration regulatory processes, review some unique aspects of pediatric cardiology and cardiac surgery that pose challenges to these processes, and discuss possible alternate pathways to cardiac device evaluation and approval for children. Children deserve to benefit from new and refined cardiac devices and technology designed explicitly for their conditions.
Key Words: cardiac devices medical devices device approval pediatric cardiology
Abbreviations: FDA—Food and Drug Administration IDE—investigational device exemption PMA—premarket approval HDE—humanitarian device exemption HUD—humanitarian use device OPC—objective performance criteria PG—performance goal OUS—outside the United States
Accepted Feb 27, 2009.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
R. H. Beekman III Alternatives proposed for pediatric cardiac device approval AAP News, July 1, 2009; 30(7): 16 - 16. [Full Text] [PDF] |
||||





